The present invention relates to tablets containing prednisolone salts and in particular prednisolone sodium phosphates. The dosage forms include ODTs and non-ODTs effervescent tablets and noneffervescent tablets and tablets meeting certain performance criteria.

A gatifloxacin and prednisolone topical ophthalmic pharmaceutical compositions for prevention and treatment of ophthalmic bacterial infections and inflammatory conditions associated with pre-surgical and/or post surgical ocular surgeries.

The present invention provides a composition for treating and/or preventing type I diabetes and an application thereof. The active ingredient of the composition is 1.) or 2.) or 3.) as follows: 1.) a mixture of a type I diabetes protein antigen and an immunosuppressor 2.) a mixture of a type I diabetes protein antigenic epitope polypeptide and an immunosuppressor 3.) a mixture of a type I diabetes protein antigen a type I diabetes protein antigenic epitope polypeptide and an immunosuppressor; th...

The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation.